Dais (DLYT) 10-Q 15 Nov 21 2021 Q3 Quarterly report Financial data

Cover

Cover - shares	9 Months Ended
	Sep. 30, 2021	Nov. 15, 2021
Cover [Abstract]
Entity Registrant Name	DAIS CORPORATION
Entity Central Index Key	0001125699
Document Type	10-Q
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Small Business	true
Entity Shell Company	false
Entity Emerging Growth Company	false
Entity Current Reporting Status	Yes
Document Period End Date	Sep. 30, 2021
Entity Filer Category	Non-accelerated Filer
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2021
Entity Common Stock Shares Outstanding		9,415,425
Document Quarterly Report	true
Document Transition Report	false
Entity Interactive Data Current	Yes
Entity File Number	000-53554
Entity Incorporation State Country Code	NY
Entity Tax Identification Number	14-1760865
Entity Address Address Line 1	11552 Prosperous Drive
Entity Address City Or Town	Odessa
Entity Address State Or Province	FL
Entity Address Postal Zip Code	33556
City Area Code	727
Local Phone Number	375-8484

CONDENSED BALANCE SHEETS

CONDENSED BALANCE SHEETS - USD ($)	Sep. 30, 2021	Dec. 31, 2020
CURRENT ASSETS:
Cash and cash equivalents	$ 133,584	$ 36,516
Accounts receivable, net	62,768	502
Other receivables	0	6,169
Inventory	92,917	65,656
Prepaid expenses	69,691	30,670
Total Current Assets	358,960	139,513
Property and equipment, net	14,320	4,501
OTHER ASSETS:
Deposits	4,780	4,780
Patents, net	153,124	153,592
Total Other Assets	157,904	158,372
TOTAL ASSETS	531,184	302,386
CURRENT LIABILITIES:
Accounts payable, including related party payables of $313,808 and $305,081 at September 30, 2021 and December 31, 2020, respectively	1,071,545	984,485
Accrued expenses, other, including interest due to related party of $877,141 and $679,239 at September 30, 2021 and December 31, 2020, respectively	1,299,866	1,515,740
Accrued compensation and related benefits	2,191,190	2,120,951
Customer deposits	56,440	43,109
Notes payable to related parties	2,174,897	2,125,600
Current portion of deferred revenue	311,156	348,656
Derivative liabilities	0	3,845,662
Note payable - due within one year, net of unamortized discount and debt costs of $95,154 and $0, respectively	410,846	26,200
Convertible notes payable, net of unamortized discount and debt costs of $216,279 and $0, respectively	3,721	1,453,960
Total Current Liabilities	7,519,661	12,464,363
Notes payable - due after one year	272,340	294,750
Total Liabilities	7,792,001	12,759,113
STOCKHOLDERS' DEFICIT
Preferred stock, undesignated; $0.01 par value; 7,990,000 shares authorized; no shares issued and outstanding	0	0
Common stock; $0.01 par value; 1,100,000,000 shares authorized; 9,415,425 shares issued and 9,414,796 shares outstanding at September 30, 2021 and 278,757 shares issued and 278,128 shares outstanding at December 31, 2020, respectively	94,154	2,788
Capital in excess of par value	49,523,885	45,976,660
Accumulated deficit	(55,416,744)	(56,974,063)
Total Stockholders Defict Non controling	(5,798,705)	(10,994,615)
Treasury stock at cost, 629 shares at September 30, 2021 and December 31, 2020, respectively	(1,462,112)	(1,462,112)
Total Stockholders' Deficit	(7,260,817)	(12,456,727)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	531,184	302,386
Preferred Stock Series A [Member]
STOCKHOLDERS' DEFICIT
Preferred stock, undesignated; $0.01 par value; 7,990,000 shares authorized; no shares issued and outstanding	0	0
Preferred Stock, Series B [Member]
STOCKHOLDERS' DEFICIT
Preferred stock, undesignated; $0.01 par value; 7,990,000 shares authorized; no shares issued and outstanding	$ 0	$ 0

CONDENSED BALANCE SHEETS (Paren

CONDENSED BALANCE SHEETS (Parenthetical) - USD ($)	Sep. 30, 2021	Dec. 31, 2020
Common stock, shares par value	$ 0.01	$ 0.01
Common stock, shares authorized	1,100,000,000	1,100,000,000
Common stock, shares issued	9,415,425	278,757
Common stock, shares outstanding	9,414,796	278,128
Treasury stock shares	629	629
Related party payables included in accounts payable	$ 313,808	$ 305,081
Note payable - due within one year, net of unamortized discount and debt costs	95,154	0
Convertible notes payable, net of unamortized discount and debt costs	216,279	0
Interest payable, related party included in accrued expenses	$ 877,141	$ 679,239
Preferred Stock Series A [Member]
Preferred stock, shares par value	$ 0.01	$ 0.01
Preferred stock, shares authorized	2,000,000	2,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Preferred Stock, Series B [Member]
Preferred stock, shares par value	$ 0.01	$ 0.01
Preferred stock, shares authorized	10,000	10,000
Preferred stock, shares issued	10	10
Preferred stock, shares outstanding	10	10
Preferred Stock Undesignated [Member]
Preferred stock, shares par value	$ 0.01	$ 0.01
Preferred stock, shares authorized	7,990,000	7,990,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0

CONDENSED STATEMENTS OF OPERATI

CONDENSED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
REVENUE
Sales	$ 116,864	$ 360,764	$ 288,854	$ 828,796
Royalty and license fees	12,500	12,500	37,500	37,500
Revenue	129,364	373,264	326,354	866,296
COST OF GOODS SOLD	90,749	213,485	173,639	481,704
GROSS MARGIN	38,615	159,779	152,715	384,592
OPERATING EXPENSES
Research and development, net of government grant proceeds of $28,651, $34,716, $89,617 and $92,050, respectively	29,814	10,573	69,660	84,799
Selling, general and administrative	305,833	276,318	1,590,907	793,062
TOTAL OPERATING EXPENSES	335,647	286,891	1,660,567	877,861
LOSS FROM OPERATIONS	(297,032)	(127,112)	(1,507,852)	(493,269)
OTHER INCOME (EXPENSE)
Interest expense	(110,938)	(223,266)	(471,746)	(811,756)
Forgiveness of debt income	146,685	0	146,685	0
Change in fair value of derivative liabilities	0	(208,916)	2,241,678	376,282
Gain on extinguishment of debt	0	0	1,148,554	0
TOTAL OTHER INCOME (EXPENSE), NET	38,459	(432,182)	3,067,883	(435,474)
NET INCOME (LOSS)	$ (261,285)	$ (559,294)	$ 1,557,319	$ (928,743)
NET INCOME (LOSS) PER COMMON SHARE, BASIC	$ (0.03)	$ (2.01)	$ 0.35	$ (3.34)
NET LOSS PER COMMON SHARE, DILUTED	$ (0.03)	$ (2.01)	$ (0.19)	$ (3.34)
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING, BASIC	9,414,796	278,128	4,494,649	278,128
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING, DILUTED	9,414,796	278,128	8,360,950	278,128

CONDENSED STATEMENT OF STOCKHOL

CONDENSED STATEMENT OF STOCKHOLDERS DEFICIT (Unaudited) - USD ($)	Total	Preferred Stock	Common Stock	Capital in Excess of Par Value	Accumulated Deficit	Treasury Stock
Balance, shares at Dec. 31, 2019		10	278,757
Balance, amount at Dec. 31, 2019	$ (9,668,994)	$ 0	$ 2,788	$ 45,976,660	$ (54,186,330)	$ (1,462,112)
Net loss	(1,830,965)				(1,830,965)
Balance, shares at Mar. 31, 2020		10	278,757
Balance, amount at Mar. 31, 2020	(11,499,959)	$ 0	$ 2,788	45,976,660	(56,017,295)	(1,462,112)
Balance, shares at Dec. 31, 2019		10	278,757
Balance, amount at Dec. 31, 2019	(9,668,994)	$ 0	$ 2,788	45,976,660	(54,186,330)	(1,462,112)
Net loss	(928,743)
Beneficial conversion feature of debt	0
Balance, shares at Sep. 30, 2020		10	278,757
Balance, amount at Sep. 30, 2020	(10,597,737)	$ 0	$ 2,788	45,976,660	(55,115,073)	(1,462,112)
Balance, shares at Mar. 31, 2020		10	278,757
Balance, amount at Mar. 31, 2020	(11,499,959)	$ 0	$ 2,788	45,976,660	(56,017,295)	(1,462,112)
Net loss	1,461,516	$ 0	$ 0	0	1,461,516	0
Balance, shares at Jun. 30, 2020		10	278,757
Balance, amount at Jun. 30, 2020	(10,038,443)	$ 0	$ 2,788	45,976,660	(54,555,779)	(1,462,112)
Net loss	(559,294)	$ 0	$ 0	0	(559,294)	0
Balance, shares at Sep. 30, 2020		10	278,757
Balance, amount at Sep. 30, 2020	(10,597,737)	$ 0	$ 2,788	45,976,660	(55,115,073)	(1,462,112)
Balance, shares at Dec. 31, 2020		10	278,757
Balance, amount at Dec. 31, 2020	(12,456,727)	$ 0	$ 2,788	45,976,660	(56,974,063)	(1,462,112)
Net loss	1,743,060	$ 0	$ 0	0	1,743,060	0
Balance, shares at Mar. 31, 2021		10	278,757
Balance, amount at Mar. 31, 2021	(10,713,667)	$ 0	$ 2,788	45,976,660	(55,231,003)	(1,462,112)
Balance, shares at Dec. 31, 2020		10	278,757
Balance, amount at Dec. 31, 2020	(12,456,727)	$ 0	$ 2,788	45,976,660	(56,974,063)	(1,462,112)
Net loss	1,557,319
Beneficial conversion feature of debt	90,000
Balance, shares at Sep. 30, 2021		10	9,415,425
Balance, amount at Sep. 30, 2021	(7,260,817)	$ 0	$ 94,154	49,523,885	(55,416,744)	(1,462,112)
Balance, shares at Mar. 31, 2021		10	278,757
Balance, amount at Mar. 31, 2021	(10,713,667)	$ 0	$ 2,788	45,976,660	(55,231,003)	(1,462,112)
Net loss	75,544	0	$ 0	0	75,544	0
Shares and warrants issued for services, shares			2,100,000
Shares and warrants issued for services, amount	751,457	0	$ 21,000	730,457	0	0
Shares and warrants issued for settlement of debt, shares			7,036,668
Shares and warrants issued for settlement of debt, amount	2,687,134	$ 0	$ 70,366	2,616,768	0	0
Balance, shares at Jun. 30, 2021		10	9,415,425
Balance, amount at Jun. 30, 2021	(7,199,532)	$ 0	$ 94,154	49,323,885	(55,155,459)	(1,462,112)
Net loss	(261,285)	0	0	0	(261,285)	0
Warrants issued with debt	110,000	0	0	110,000	0	0
Beneficial conversion feature of debt	90,000	$ 0	$ 0	90,000	0	0
Balance, shares at Sep. 30, 2021		10	9,415,425
Balance, amount at Sep. 30, 2021	$ (7,260,817)	$ 0	$ 94,154	$ 49,523,885	$ (55,416,744)	$ (1,462,112)

CONDENSED STATEMENTS OF CASH FL

CONDENSED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income (loss)	$ 1,557,319	$ (928,743)
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization of deferred debt issue costs	0	5,848
Depreciation and amortization	15,767	33,301
Stock based compensation	751,457	0
Change in fair value of derivative liability	(2,241,678)	(376,282)
Forgiveness of debt	(146,685)
Gain on extinguishment of debt	(1,148,554)	0
Non-cash interest expenses	124,290	368,312
Amortization of debt discount and costs	32,557	101,899
Gain on extinguishment of debt	0	0
Legal fees paid through proceeds of notes payable	0	0
(Increase) decrease in:
Accounts receivable	(62,266)	12,883
Inventory	(27,261)	11,138
Other receivables	6,169	22,019
Prepaid expenses/Other assets	(39,021)	(12,738)
Increase (decrease) in:
Accounts payable	87,060	36,423
Accrued expenses	388,764	412,291
Customer deposits	13,331	(41,152)
Deferred revenue	(37,500)	(37,500)
Net cash used in operating activities	(726,251)	(392,301)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of equipment	(11,541)	0
Increase in patent costs	(13,577)	(18,633)
Net cash used in investing activities	(25,118)	(18,633)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from notes payable - related parties	49,297	135,000
Proceeds from notes payable	825,340	348,750
Repayment of note	(26,200)	(54,000)
Net cash provided by financing activities	848,437	429,750
Net increase in cash	97,068	18,816
Cash, beginning of period	36,516	4,083
Cash, end of period	133,584	22,899
SUPPLEMENTAL CASH FLOW INFORMATION:
Cash paid for interest	0	1,537
NON-CASH FINANCING AND FINANCING ACTIVITIES
Issuance of common stock and warrants upon settlement of notes and accrued interest	2,687,134	0
Notes and accrued interest settled with common stock and warrants	2,107,414	0
Derivative liability extinguished	1,728,274	0
Relative fair value of warrant, recorded as debt discount	110,000	0
Beneficial conversion feature of debt	90,000	0
Common stock to be issued for finance cost, accrued and recorded as debt discount	120,990	0
Original issued discount, deducted from proceeds and recorded as debt discount	20,000	0
Debt costs deducted from proceeds	$ 3,000	$ 0

Background Information

Background Information	9 Months Ended
	Sep. 30, 2021
Background Information
Note 1. Background Information	Note 1. Background Information Dais Corporation (“Dais”, “us,” “we,”, the “Company”), a New York corporation, is a nano-structured polymer technology materials company having developed and now commercializing products using its platform of nanomaterial called Aqualyte™. The Company was incorporated in April 1993 and its corporate headquarters is in Odessa, Florida. Environmental, Societal, and Governance (ESG) The Company takes its role and responsibilities with an eye to the long view, and a sense of leadership. Below is the beginning of a new section to be found in the Company’s filings going forward. It is the beginning of our ESG programs, with the center piece being our products, driven by our deep concern about the value of ESG in the workplace. Environmental Dais has a serious focus on external environmental challenges (Climate Crisis, Sustainability) facing our country and our Planet. We believe with modest adoption of the Company’s products worldwide (having an estimated 15% market share in key HVAC, Water, and Energy markets) where Dais is focused our products alone could account for upwards of 5 billion metric tons saved (avoided) of CO 2 2 Social Concerns Dais, as a small company, is a diverse employer and manager of talented people from many countries around the world. The Company sees innovation and agility as massive (and expanding) benefits of diversity. Governance Twenty-Five percent of Dais’s Board of Director’s is classified as diverse. The Dais Board drives a high standard of business ethics, anti-competitive practices, looks for corruption, and seeks to provide accounting transparency for stakeholders. Our Products The Company’ uses its proprietary Aqualyte nanomaterial to integrate it into traditional or new product form factors. It is management’s belief based on 3 rd Nanomaterial Platform - Aqualyte™ Aqualyte Nanomaterial is made from commercially available polymer resin and industrial grade solvents which are mixed using a proprietary process with traditional industrial equipment, and solvents. The resin and the solvents are commercially available from chemical supply houses. Our process changes the molecular properties of the starting polymer resins such that in the final Aqualyte form there are very different properties. Aqualyte is a technology with carefully tailored properties for use in air, energy, and water applications. This modified block copolymer membrane with a nanoscale structure serves as the foundation of the Dais product line. The material forms a nonporous plastic membrane able to move water moisture through microscopic hydrophilic channels while blocking passage of most gases and volatile compounds. Company and third-party data suggest the membrane is robust, has no pores which will clog or accumulate bacterial or fungal growth. Multiple independent third parties have validated the performance of Aqualyte and the protection it provides from the harmful effects of viral and bacterial pathogens. This is a major feature which differentiates products made using the Aqualyte Nanomaterial Platform. The Company continues to develop next generation versions of its Aqualyte nanomaterial working to increase performance, add new features, and reduce production cost. The Company sells Aqualyte to skilled OEMs using it’s features and properties to create their own improved or new products in a range of applications. ConsERV™ We continue to work to expand sales channels to drive growth of revenues of the ConsERV product, which uses Aqualyte Nanomaterial in an HVAC energy conservation and emissions lowering product (branded ConsERV). According to various tests, the product saves on average 30% on HVAC operating costs, lowers CO 2 Basis of Presentation The Company’s accompanying condensed financial statements are unaudited, but in the opinion of management reflect all adjustments necessary to fairly state the Company’s financial position, results of operations, stockholders’ deficit and cash flows as of and for the dates and periods presented. The financial statements of the Company are prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information. The unaudited financial statements and notes are presented as permitted by Form 10-Q. Accordingly, certain information and note disclosures normally included in financial statements have been omitted although the Company generally believes that the disclosures are adequate to ensure that the information presented is not misleading. The accompanying financial statements and notes should be read in conjunction with the audited financial statements and notes of the Company for the fiscal year ended December 31, 2020 included in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission on September 17, 2021. The results of operations for the three- and nine-month periods ended September 30, 2021 are not necessarily indicative of the results that may be expected for any future quarters or for the entire year ending December 31, 2021.

Going Concern and Managements P

Going Concern and Managements Plans	9 Months Ended
	Sep. 30, 2021
Going Concern and Managements Plans
Note 2. Going Concern and Management's Plans	Note 2. Going Concern and Management’s Plans The accompanying financial statements have been prepared assuming the Company will continue as a going concern. Although the Company generated income of $1,557,319 for the nine months ended September 30, 2021, this resulted primarily from a noncash gain on change in derivative liabilities of $2,241,678 and a noncash gain on extinguishment of debt of $1,148,554, along with noncash gain on forgiveness of debt of $146,685. The Company has incurred significant losses since inception and, as of September 30, 2021, the Company has an accumulated deficit of $55,416,744, total stockholders’ deficit of $7,260,817, negative working capital of $7,160,701 and cash of $133,584. The Company used $726,251 and $392,301 of cash in operations during the nine months ended September 30, 2021 and 2020, respectively, which was funded primarily by loan proceeds from related parties and third parties. There is no assurance that any such financing will be available in the future. These factors raise substantial doubt about the Company’s ability to continue as a going concern. The Company is currently pursuing the following sources of short and long-term working capital: 1. The Company is actively working with selected targeted parties who are interested in licensing, purchasing the rights to, or establishing a joint venture to commercialize applications of the Company’s technology; 2. The Company continues to seek capital from certain strategic and/or government grant opportunities and related sources. These sources may, pursuant to any agreements that may be developed in conjunction with such funding, assist in the product definition and design, roll-out and channel penetration of products; and 3. The Company is actively working with newer investors, private equity companies, purchase order financing parties, and its existing debt holders to restructure its existing debt and obtain short and long-term working and growth capital. Any failure by the Company to timely procure additional financing or investment adequate to fund the ongoing operations, including planned product development initiatives and commercialization efforts, will have material adverse consequences on the Company’s financial condition, results of operations and cash flows as could any unfavorable terms. There are no assurances the Company will be able to obtain the financing and planned product development commercialization. Accordingly, the Company may not have the ability to continue as a going concern. The financial statements of the Company do not include any adjustments relating to the recoverability and classification of recorded assets, or the amounts and classifications of liabilities that might be necessary should the Company be unable to continue as a going concern. The Company has experienced and increase in inquiries relating to its’ ConsERV product and has responded to bid requests generated through our network of sales representatives. Converting these bids into sales will increase cash-flow relating to operations, reducing the amount of anticipated short-term financing.

Significant Accounting Policies

Significant Accounting Policies	9 Months Ended
	Sep. 30, 2021
Significant Accounting Policies
Note 3. Significant Accounting Policies	Note 3. Significant Accounting Policies The significant accounting policies followed are: Use of estimates - Significant estimates underlying the Company’s reported financial position and results of operations include the allowance for doubtful accounts, fair value of derivative liabilities, valuation allowance on deferred taxes and the warranty reserve. Revenue recognition - In certain instances, the Company’s ConsERV system product may carry a limited warranty of up to one year for all parts contained therein except for the energy recovery ventilator core produced and sold by the Company. The distributor of the ConsERV system may carry a limited warranty of up to ten years. The limited warranty includes replacement of defective parts for the ConsERV system and includes workmanship and material failure for the ConsERV core. The Company recorded an accrual of $91,531 for future warranty expenses at September 30, 2021 and December 31, 2020, which is included in accrued expenses, other. Royalty revenue is recognized as earned. The Company recognized royalty revenue of $0 for the three and nine months ended September 30, 2021 and 2020, respectively. Revenue derived from the sale of licenses is deferred and recognized as license fee revenue on a straight-line basis over the life of the license, or until the license arrangement is terminated. The Company recognized license fee revenue of $12,500 and $12,500 for the three months ended September 30, 2021 and 2020, respectively and $37,500 and $37,500 for the nine months ended September 30, 2021 and 2020, respectively. The Company accounts for revenue arrangements with multiple elements under the provisions of ASC Topic 605-25, “Revenue Recognition-Multiple-Element Arrangements.” To account for these agreements, the Company must identify the deliverables included within the agreement and evaluate which deliverables represent separate units of accounting based on certain criteria being met, including whether the delivered element has stand-alone value to the licensee. The consideration received is allocated among the separate units of accounting, and the applicable revenue recognition criteria are applied to each of the separate units. Shipping and handling fees billed to customers are included in revenue. Shipping and handling fees associated with freight are generally included in cost of revenue. Cash and cash equivalents - Concentrations – Fair Value of Financial Instruments - Inventory - Property and equipment - Intangible assets Research and development expenses and funding proceeds - Derivative Liability Fair Value Measurements The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy are described below: · Level 1 - Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities. · Level 2 - Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, including quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability (e.g. interest rates); and inputs that are derived principally from or corroborated by observable market data by correlation or other means. · Level 3 - Inputs that are both significant to the fair value measurement and unobservable. A financial asset or liability’s classification within the hierarchy is determined based on the lowest level input that is significant to the fair value measurement. The Company has recorded a derivative liability for its convertible notes which contain variable conversion prices. The table below summarizes the fair values of our financial liabilities as of September 30, 2021: Fair Value at September 30, Fair Value Measurement Using 2021 Level 1 Level 2 Level 3 Derivative liability $ - $ - $ - $ - The reconciliation of the derivative liability measured at fair value on a recurring basis using unobservable inputs (Level 3) is as follows for the nine months ended September 30, 2021 and 2020: September 30, September 30, 2021 2020 Balance, beginning of period $ 3,845,662 $ 2,349,471 Additions 124,290 368,312 Extinguished derivative liability (1,728,274 ) - Change in fair value of derivative liabilities (2,241,678 ) (376,282 ) Balance, end of period $ - $ 2,341,501 Earnings (loss) per share Reconciliation of diluted loss per share for the nine-month period ended September 30, 2021, is as follows: Nine Months Ended Net income attributable to common shareholders $ 1,557,319 Income attributable to note derivatives Change in fair value of derivatives (2,241,678 ) Gain on extinguishment of debt (1,148,554 ) Expense attributable to note derivatives Interest expense 216,378 Diluted loss attributable to common shareholders $ (1,616,535 ) Basic shares outstanding 4,494,649 Derivative notes and interest shares 3,866,301 Diluted shares outstanding 8,360,950 Diluted loss per share $ (0.19 ) Recent Accounting Pronouncements - In December 2019, the FASB issued ASU 2019-12, “ Simplifying the Accounting for Income Taxes Other recent accounting pronouncements issued by the FASB and the SEC did not or are not believed by management to have a material impact on the Company’s present or future consolidated financial statements.

Accrued Expenses Other

Accrued Expenses Other	9 Months Ended
	Sep. 30, 2021
Accrued Expenses Other
Note 4. Accrued Expenses, Other	Note 4. Accrued Expenses, Other Accrued expenses, other consists of the following: September 30, December 31, 2021 2020 Accrued expenses, other $ 189,278 $ 185,656 Accrued common stock to be issued for financing cost 120,990 - Accrued interest 898,067 1,238,553 Accrued warranty costs 91,531 91,531 $ 1,299,866 $ 1,515,740

Related Party Transactions

Related Party Transactions	9 Months Ended
	Sep. 30, 2021
Related Party Transactions
Note 5. Related Party Transactions	Note 5. Related Party Transactions The Company rents a building that is owned by two stockholders of the Company, one of which is the Chief Executive Officer. Rent expense for this building is $4,066 per month, including sales tax. The Company recognized rent expense related to this lease of $12,198 and $12,198 for the three months ended September 30, 2021 and 2020, respectively and $36,594 and $36,594 for the nine months ended September 30, 2021 and 2020, respectively The lease term will terminate upon 30 days’ written notice from landlord or 90 days written termination from us. The lease is considered to be short term or month to month. On June 24, 2016, the Company entered into a Loan and Security Agreement (“Security Agreement”) with the entity now known as PKT Strategic Assets, LLC (the “Holder”) pursuant to which the Company issued a Senior Secured Promissory Note for $150,000(the “Note”). The Note has an interest rate is 12% per annum compounded daily with a minimum interest payment of $2,000. The Note grants the Holder a secured interest in all the assets of the Company. During 2016 to the period ended September 30, 2021, the Holder extended the Note pursuant to various amendments. Pursuant to the amendments, the principal amount and interest totaled $3,040,838 (not including possible fees and other expenses). The Holder’s corporation is majority controlled by Ms. Tangredi, related to Tim Tangredi: the Company’s CEO and stockholder, and therefore, is a Related Party of the Company. The Company is to pay the Holder the principal, plus all interest and fees due in accordance with terms and conditions of the Security Agreement on the earlier of: (i) the date upon which the Company secures funds, regardless of source, equal to or exceeding, in the aggregate, $1,000,000 or (ii.). November 1, 2021 which has expired. The Holder has not declared the Note in Default as the Parties are actively renegotiating a new Maturity Date (the “Maturity Date”) with changes terms and conditions. The Parties fully expect to come to reasonable terms on all issues during the fourth quarter of 2021. The Company has accrued compensation due to the Chief Executive Officer as of September 30, 2021 and December 31, 2020 of $2,053,878 and $1,983,639, respectively, included in accrued compensation and related benefits in the accompanying balance sheets. Subsequently, the Parties have agreed to exchange the sum for equity in the Company. See Note 11. Subsequent Events for more information. On October 12, 2019, the Company entered into a promissory note with an entity controlled by our Chief Executive Officer in the amount of $10,000. The note bears interest at 10% per year and matures on October 12, 2021. Interest expense on the note was $150 for each of the three month periods ended September 30, 2021 and 2020, respectively, and was $450 for each of the nine month periods ended September 30, 2021 and 2020, respectively. Accrued interest was $1,200 and $750 at September 30, 2021 and December 31, 2020, respectively.

Equity Transactions

Equity Transactions	9 Months Ended
	Sep. 30, 2021
Equity Transactions
Note 6. Equity Transactions	Note 6. Equity Transactions Preferred Stock As of September 30, 2021 and December 31, 2020, the Company’s Board of Directors noted it had in previous years authorized a total of 10,000,000 shares of preferred stock with a par value of $0.01 to be issued in series with terms and conditions to be determined by the Board of Directors. 2,000,000 of the shares of preferred stock has been designated as Class A Preferred Stock. The Class A Preferred Stock shall entitle the holder thereof to 150 votes on all matters submitted to a vote of the stockholders of the Company. 10,000 of the shares of preferred stock has been designated as Class B Preferred Stock. The Class B Stock includes the right to vote in an amount equal to 51% of the votes to approve certain corporate actions, including, without limitation, changing the name of the Company and increasing the number of authorized shares. Upon any liquidation, dissolution or winding up of the Company, no distribution shall be made to the holders of shares of stock ranking junior (either as to dividends or upon liquidation, dissolution or winding up) to the Class A or Class B Preferred Stock unless, prior thereto, the holders of shares of Class A or Class B Preferred Stock shall have received $1.50 per share (the “Stated Amount”). The Class A and Class B Preferred Stock shall rank, with respect to the payment of liquidation, dividends and the distribution of assets, senior to the Company’s Common Stock. The Holder (as defined in the Class A Preferred Stock certificate of designations) of the Class A Preferred Stock may convert all or part of the outstanding and unpaid Stated Amount (as defined in the Class A Preferred Stock certificate of designations) into fully paid and non-assessable shares of the Company’s common stock at the Conversion Price (as defined in the Class A Preferred Stock certificate of designations). The number of shares receivable upon conversion equals the Stated Amount divided by the Conversion Price. The Conversion Price shall be equal to the 75% of the average closing price for the 30 trading days prior to the election to convert. At no time will the Company convert any of the Stated Amount into common stock if that would result in the Holder beneficially owning more than 49% of the sum of the voting power of the Company’s outstanding shares of common stock plus the voting power of the Class A Preferred Stock. No shares of Class A Preferred Stock have been issued. The shares of the Class B Preferred Stock shall be automatically redeemed by the Company at $0.01 per share on the date that Tim N. Tangredi ceases, for any reason, to serve as an officer, director, or consultant of the Company. Common Stock As of September 30, 2021 and December 31, 2020, the Company’s Board of Directors has authorized a total of 1,100,000,000 shares of common stock with a par value of $0.01 to be issued in series with terms and conditions to be determined by the Board of Directors. During the three months ended June 30, 2021, the Company issued 7,036,668 shares of common stock and 2,826,733 common stock purchase warrants in settlement of convertible notes payable and related accrued interest. The shares are valued at $1,829,534 and the Warrants are valued at $857,600. During the three months ended June 30, 2021, the Company issued 2,100,000 shares of common stock, valued at $567,000, for services. There were no common stock transactions in 2020. Options and Warrants In January 2021, outstanding Options and Warrants held by Employees, Board Members and the Company’s Secured Note Holder were surrendered by Holders to the Company. The 2,826,733 warrants issued in 2021 in connection with the settlement of debt have an exercise price of $0.30 per share and expire on June 30, 2022. The fair value of the warrants was $857,600, determined using the Black Scholes Model with the following assumptions: (1) risk free interest rate of 0.05%; (2) dividend yield of 0%; (3) volatility factor of the expected market price of the Company’s common stock of 367%; and (4) an expected life of 11.5 months. During the three months ended June 30, 2021, the Company issued 700,000 warrants for services. The warrants have an exercise price of $0.05 per share and expire on May 18, 2022. The fair value of the warrants was $184,457, determined using the Black Scholes Model with the following assumptions: (1) risk free interest rate of 0.06%; (2) dividend yield of 0%; (3) volatility factor of the expected market price of the Company’s common stock of 376%; and (4) an expected life of 1 year. In September 2021, the Company issued 1,466,666 warrants in connection with a note in the amount of $220,000. The warrants have an exercise price of $0.15 per share and expire on September 21, 2026. The relative fair value of the warrants was $110,000, determined using the Black Scholes Model with the following assumptions: (1) risk free interest rate of 0.84%; (2) dividend yield of 0%; (3) volatility factor of the expected market price of the Company’s common stock of 389%; and (4) an expected life of 5 years.

Notes Payable

Notes Payable	9 Months Ended
	Sep. 30, 2021
Notes Payable
Note 7. Notes Payable	Note 7. Notes Payable Paycheck Protection Program Loans On January 25, 2021, the Company received $122,340 in a loan borrowed from a bank pursuant to the Paycheck Protection Program under the CARES Act guaranteed by the Small Business Administration (“SBA”), which we expect to be forgiven in part or in full, subject to our compliance with the conditions of the Paycheck Protection Program. If not forgiven, the terms on the note provide for interest at 1% per year and the note mature in 24 months, with 18 monthly payments of $8,146 beginning after the initial 6 month deferral period for payments. On April 29, 2020, the Company received $144,750 in a loan borrowed from a bank pursuant to the Paycheck Protection Program under the CARES Act guaranteed by the Small Business Administration (“SBA”), which we expect to be forgiven in part or in full, subject to our compliance with the conditions of the Paycheck Protection Program. If not forgiven, the terms on the note provide for interest at 1% per year and the note mature in 24 months, with 18 monthly payments of $8,146 beginning after the initial 6 month deferral period for payments. This loan was subsequently forgiven in full on August 29, 2021 and the Company recorded forgiveness of debt income of $146,685, including accrued interest forgiven of $1,935. Small Business Administration Loan On June 12, 2020, the Company received $150,000 in a loan borrowed from the SBA. Installment payments, including principal and interest, of $731 monthly, will begin 12 months from the date of the note. The balance of principal and interest will mature 30 years from the date of the note. Interest will accrue at the rate of 3.75% per year. On March 16, 2021, the U.S. Small Business Administration announced that the deferment period for the repayment would be extended an additional 12 months. JMS Investments Between April of 2021 and September 30, 2021, JMS Investments of Staten Island, NY, USA invested $376,000 in seven separate transactions. The sums are repayable in the form of one-year demand notes having an interest rate of 8.5%. GEX Management, Inc. On August 30, 2021, the Company entered into a promissory note with GEX Management, Inc. The note matures on February 28, 2022 and bears interest at 10% per year. In connection with this note, the Company has agreed to issue 1,000,000 shares of common stock to the lender. These shares have not been issued at September 30, 2021. The shares to be issued have been valued at $120,990, which has been recorded as debt discount. The discount will be amortized to interest expense over the term of the note, and $25,836 was amortized during the three and nine months ended September 30, 2021. The value of the shares has been included in accrued expenses at September 30, 2021. GS Capital Partners, LLC Convertible Note On September 20, 2021, the Company entered into a promissory note with GS Capital Partners, LLC. The note matures on September 20, 2022 and bears interest at 8% per year. The Company received proceeds of $197,000, after deduction of $20,000 of original issue discount and $3,000 of costs. In connection with this note, the Company has issued a warrant to purchase 1,466,666 shares of common stock to the lender. The warrants have an exercise price of $0.15 per share and expire on September 21, 2026. The relative fair value of the warrants was $110,000, determined using the Black Scholes Model with the following assumptions: (1) risk free interest rate of 0.84%; (2) dividend yield of 0%; (3) volatility factor of the expected market price of the Company’s common stock of 389%; and (4) an expected life of 5 years. The note is convertible into shares of common stock at a fixed conversion price of $0.10 per share. The company has recorded a beneficial conversion feature of $90,000. A total of $220,000 has been recorded as debt discount, and 3,000 has been recorded as deferred debt costs. The discount and costs will be amortized to interest expense over the term of the note, and $6,721 was amortized during the three and nine months ended September 30, 2021. The sums advanced by GS Capital Partners and JMS Investments together form a “bridge loan” for use by the Company to, among other actions, bring all filings current to return to fully reporting status with the SEC and OTC, and allow the Company to obtain the critical resources which allow Dais to grow as management and the bridge investors believe is possible using the company’s proven nanotechnology in sustainable product in a worldwide market. Currently, JMS Investments, the Company, and the Senior Secured Note Holder are negotiating the definitive investment plan along with terms and uses of proceeds. It is expected the full investment plan will be ready for announcement in the fourth quarter of 2021.

Convertible Notes Payable and E

Convertible Notes Payable and Exchange Program	9 Months Ended
	Sep. 30, 2021
Convertible Notes Payable and Exchange Program
Note 8. Convertible Notes Payable and Exchange Program	Note 8. Convertible Notes Payable and Exchange Program Debt to Equity Exchange Program In the period from June 2017 through the end of December 2019, the Company entered eight Convertible Note Holder agreements with eight Note Holders totaling, with all fees, interest, and principal, $2,008,812 as of December 31, 2020. The notes were not considered to be in default and were being renegotiated at March 31, 2021. Subsequently, as of May 31, 2021, each Convertible Noteholder received their fees, interest, and principal totaling $2,107,414 in shares of Common stock of the Company (at $.030 per share) with 50% warrant coverage (1 year cash warrant with a strike price of $0.30). All documents were executed by June 30, 2021 with all equity/warrants issued by July 31, 2021. The Company issued 7,036,668 Common shares, and 2,826,733 Warrant shares in this transaction. The Company’s convertible promissory notes at September 30, 2021 and December 31, 2020 are as follows: September 30, 2021 December 31, 2020 Convertible notes payable, bearing interest at 8-10% $ - $ 1,453,960 Current portion $ - $ 1,453,960 The company entered into various convertible notes during 2019 and 2018, aggregating $1,453,960 at the time of settlement in the second quarter of 2021. During the second quarter of 2021 the Company issued 7,036,668 shares of common stock, valued at $1,829,534 and 3,576,733 warrants, valued at $857,600, in settlement of $1,453,960 of notes payable and $653,454 of accrued interest. Derivative liability of $1,728,274 was extinguished as a result of the settlement. The Company recorded a gain on extinguishment of $1,148,554. During the nine months ended September 30, 2020, the Company amortized $101,899 of debt discount and $5,848 of debt issue costs to interest expense.

Derivative Liabilities

Derivative Liabilities	9 Months Ended
	Sep. 30, 2021
Derivative Liabilities
Note 9. Derivative Liabilities	Note 9. Derivative Liabilities The Company has identified certain embedded derivatives related to its convertible notes. Since the notes are convertible into a variable number of shares or have a price reset feature, the conversion features of those notes are recorded as derivative liabilities. The accounting treatment of derivative financial instruments requires that the Company record fair value of the derivatives as of the inception date and to adjust to fair value as of each subsequent balance sheet date. The Company has recorded additions to the derivative conversion liabilities related to the conversion feature attributable to interest accrued during the period. These additions totaled $0 and $106,366 for the three months ended September 30, 2021 and 2020, respectively, and $124,290 and $368,312 for the nine months ended September 30, 2021 and 2020, respectively and were charged to interest expense. During the three and nine months ended September 30, 2021, through the date of settlement of the debt, the Company recorded income of $0 and $2,241,678 related to the change in the fair value of the derivatives. The fair value of the embedded derivatives was $1,728,274 at the date of settlement, determined using the Black Scholes Model with the following assumptions: (1) risk free interest rate of 0.01%; (2) dividend yield of 0%; (3) volatility factor of the expected market price of the Company’s common stock of 315%; and (4) an expected life of 3 months. During the three and nine months ended September 30, 2020, the Company recorded expense of $208,916 and income of $376,282, respectively, related to the change in the fair value of the derivatives. During the second quarter of 2021 the Company issued 7,036,668 shares of common stock, valued at $1,829,534 and 2,826,733 warrants, valued at $857,600, in settlement of $1,453,960 of notes payable and $653,454 of accrued interest. Derivative liability of $1,728,274 was extinguished because of the settlement. The Company recorded a gain on extinguishment of $1,148,554.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2021
Commitments and Contingencies
Note 10. Commitments and Contingencies	Note 10. Commitments and Contingencies Litigation From time to time, claims are made against the Company in the ordinary course of its business, which could result in litigation. Claims and associated litigation are subject to inherent uncertainties and unfavorable outcomes could occur, such as monetary damages, fines, penalties, or injunctions prohibiting the Company from selling one or more products or engaging in other activities. The occurrence of an unfavorable outcome in any specific period could have a material adverse effect on the Company’s results of operations for that period or future periods. In 2015, the Company commenced an action for the cancellation of shares issued to Soex (the “Shares”) in connection with a breached Securities Purchase Agreement and Distribution Agreement entered 2014. The Soex Litigation was tried in U.S. District Court for the Middle District of Florida in October of 2018. The jury at the conclusion of the trial did not award monetary damages to either party for claims or counterclaims. On October 24, 2018, the Company initiated a third lawsuit against an affiliate of Soex, Zhongshan Trans-Tech New Material Technology Co. Ltd. Zhongshan, China, (“Transtech”), and the Chairperson of the affiliate and Soex, based on new information learned by the Company. The Company will seek maximum relief and damages for this on-going and growing illegal misuse the Company’s Intellectual Property. The Company feels this third action will lead in a judgment in favor of the Company. On October 8, 2021 the Company was notified of a usual order by the Federal District Court judge who oversaw the initial 2018 proceedings. This activity was initiated at the request of Soex’s counsel. The Order awards the defendant (Soex) $300,568 in attorney’s fees and $82,096.91 in costs for a total award of $382,664.91 to be paid by Dais. The Order doesn't specify the date by which the award needs to be paid. The Company will vigorously defend itself against this Order, as well as move on all possible avenues open to it to stop, what Management believes, is an on-going misuse of the Company’s core Intellectual Property. The Company believes – based on the content of the Order and other admissions and actions on the part of others – it has a chance to prevail in an appeal to the benefit of the Company and its shareholders. Accounts Payable The firms below have pursued legal action against the Company to collect overdue accounts payable sums. The Company is working with each to enter into a settlement plan, or “pay over time” payment plan. To date the Company has one agreement in place with SoftinWay. Company Sum Owned Payment Plan Legal Action Old Dominion Freight Line $ 13,576.95 No Yes Power Plant Services $ 85,199.11 No Yes SoftinWay $ 15,350.00 Yes Yes The O-Ring Store $ 10,334.00 No Yes Total $ 124,459.06

Subsequent Event

Subsequent Event	9 Months Ended
	Sep. 30, 2021
Subsequent Event
Note 11. Subsequent Events	Note 11. Subsequent Events 1. The Company has accrued compensation due to the Chief Executive Officer (“Employee”) beginning in 2004, of $2,053,878 and $1,983,639 at September 30, 2021 and December 31, 2020, respectively, included in accrued compensation and related benefits in the accompanying balance sheets. A Five-year cashless warrant for 5,134,690 shares with a strike price of $.08 will be issued to Employee to reduce the Company’s indebtedness by 75% leaving a balance of $536,000. 2. In November of 2021, the Company received additional advances from or through JMS Investments, LLC . Each advance is in the form of a demand note having an interest rate of 8.5%. The total investment between April 2021 and November 2021 is $536,000. The November 2021 additional sums are: Date Sum Received November 2, 2021 $ 30,000 November 3, 2021 $ 100,000 November 4, 2021 $ 30,000 No other material events have occurred after September 30, 2021 requiring recognition or disclosure in the financials.

Significant Accounting Polici_2

Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2021
Significant Accounting Policies
Use of estimates	Use of estimates - Significant estimates underlying the Company’s reported financial position and results of operations include the allowance for doubtful accounts, fair value of derivative liabilities, valuation allowance on deferred taxes and the warranty reserve.
Revenue recognition	Revenue recognition - In certain instances, the Company’s ConsERV system product may carry a limited warranty of up to one year for all parts contained therein except for the energy recovery ventilator core produced and sold by the Company. The distributor of the ConsERV system may carry a limited warranty of up to ten years. The limited warranty includes replacement of defective parts for the ConsERV system and includes workmanship and material failure for the ConsERV core. The Company recorded an accrual of $91,531 for future warranty expenses at September 30, 2021 and December 31, 2020, which is included in accrued expenses, other. Royalty revenue is recognized as earned. The Company recognized royalty revenue of $0 for the three and nine months ended September 30, 2021 and 2020, respectively. Revenue derived from the sale of licenses is deferred and recognized as license fee revenue on a straight-line basis over the life of the license, or until the license arrangement is terminated. The Company recognized license fee revenue of $12,500 and $12,500 for the three months ended September 30, 2021 and 2020, respectively and $37,500 and $37,500 for the nine months ended September 30, 2021 and 2020, respectively. The Company accounts for revenue arrangements with multiple elements under the provisions of ASC Topic 605-25, “Revenue Recognition-Multiple-Element Arrangements.” To account for these agreements, the Company must identify the deliverables included within the agreement and evaluate which deliverables represent separate units of accounting based on certain criteria being met, including whether the delivered element has stand-alone value to the licensee. The consideration received is allocated among the separate units of accounting, and the applicable revenue recognition criteria are applied to each of the separate units. Shipping and handling fees billed to customers are included in revenue. Shipping and handling fees associated with freight are generally included in cost of revenue.
Cash and cash equivalents	Cash and cash equivalents -
Concentrations	Concentrations –
Fair Value of Financial Instruments	Fair Value of Financial Instruments -
Inventory	Inventory -
Property and equipment	Property and equipment -
Intangible assets	Intangible assets
Research and development expenses and funding proceeds	Research and development expenses and funding proceeds -
Derivative liability	Derivative Liability
Fair Value Measurements	Fair Value Measurements The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy are described below: · Level 1 - Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities. · Level 2 - Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, including quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability (e.g. interest rates); and inputs that are derived principally from or corroborated by observable market data by correlation or other means. · Level 3 - Inputs that are both significant to the fair value measurement and unobservable. A financial asset or liability’s classification within the hierarchy is determined based on the lowest level input that is significant to the fair value measurement. The Company has recorded a derivative liability for its convertible notes which contain variable conversion prices. The table below summarizes the fair values of our financial liabilities as of September 30, 2021: Fair Value at September 30, Fair Value Measurement Using 2021 Level 1 Level 2 Level 3 Derivative liability $ - $ - $ - $ - The reconciliation of the derivative liability measured at fair value on a recurring basis using unobservable inputs (Level 3) is as follows for the nine months ended September 30, 2021 and 2020: September 30, September 30, 2021 2020 Balance, beginning of period $ 3,845,662 $ 2,349,471 Additions 124,290 368,312 Extinguished derivative liability (1,728,274 ) - Change in fair value of derivative liabilities (2,241,678 ) (376,282 ) Balance, end of period $ - $ 2,341,501
Earnings (loss) per share	Earnings (loss) per share Reconciliation of diluted loss per share for the nine-month period ended September 30, 2021, is as follows: Nine Months Ended Net income attributable to common shareholders $ 1,557,319 Income attributable to note derivatives Change in fair value of derivatives (2,241,678 ) Gain on extinguishment of debt (1,148,554 ) Expense attributable to note derivatives Interest expense 216,378 Diluted loss attributable to common shareholders $ (1,616,535 ) Basic shares outstanding 4,494,649 Derivative notes and interest shares 3,866,301 Diluted shares outstanding 8,360,950 Diluted loss per share $ (0.19 )
Recent Accounting Pronouncements	Recent Accounting Pronouncements - In December 2019, the FASB issued ASU 2019-12, “ Simplifying the Accounting for Income Taxes Other recent accounting pronouncements issued by the FASB and the SEC did not or are not believed by management to have a material impact on the Company’s present or future consolidated financial statements.

Significant Accounting Polici_3

Significant Accounting Policies (Tables)	9 Months Ended
	Sep. 30, 2021
Significant Accounting Policies
Schedule of fair value of derivative liability	Fair Value at September 30, Fair Value Measurement Using 2021 Level 1 Level 2 Level 3 Derivative liability $ - $ - $ - $ -
Schedule of reconciliation of the derivative liability	September 30, September 30, 2021 2020 Balance, beginning of period $ 3,845,662 $ 2,349,471 Additions 124,290 368,312 Extinguished derivative liability (1,728,274 ) - Change in fair value of derivative liabilities (2,241,678 ) (376,282 ) Balance, end of period $ - $ 2,341,501
Schedule of diluted loss per share	Nine Months Ended Net income attributable to common shareholders $ 1,557,319 Income attributable to note derivatives Change in fair value of derivatives (2,241,678 ) Gain on extinguishment of debt (1,148,554 ) Expense attributable to note derivatives Interest expense 216,378 Diluted loss attributable to common shareholders $ (1,616,535 ) Basic shares outstanding 4,494,649 Derivative notes and interest shares 3,866,301 Diluted shares outstanding 8,360,950 Diluted loss per share $ (0.19 )

Accrued Expenses Other (Tables)

Accrued Expenses Other (Tables)	9 Months Ended
	Sep. 30, 2021
Accrued Expenses Other
Schedule of accrued expenses, other	September 30, December 31, 2021 2020 Accrued expenses, other $ 189,278 $ 185,656 Accrued common stock to be issued for financing cost 120,990 - Accrued interest 898,067 1,238,553 Accrued warranty costs 91,531 91,531 $ 1,299,866 $ 1,515,740

Convertible Notes Payable and_2

Convertible Notes Payable and Exchange Program (Tables)	9 Months Ended
	Sep. 30, 2021
Convertible Notes Payable and Exchange Program
Schedule of convertible notes payable	September 30, 2021 December 31, 2020 Convertible notes payable, bearing interest at 8-10% $ - $ 1,453,960 Current portion $ - $ 1,453,960

Commitments and Contingencies (

Commitments and Contingencies (Tables)	9 Months Ended
	Sep. 30, 2021
Commitments and Contingencies
Schedule of pursued legal action	Company Sum Owned Payment Plan Legal Action Old Dominion Freight Line $ 13,576.95 No Yes Power Plant Services $ 85,199.11 No Yes SoftinWay $ 15,350.00 Yes Yes The O-Ring Store $ 10,334.00 No Yes Total $ 124,459.06

Subsequent Event (Tables)

Subsequent Event (Tables)	9 Months Ended
	Sep. 30, 2021
Subsequent Event
Schedule of subsequent events	Date Sum Received November 2, 2021 $ 30,000 November 3, 2021 $ 100,000 November 4, 2021 $ 30,000

Going Concern and Managements_2

Going Concern and Managements Plans (Details Narrative) - USD ($)	3 Months Ended						9 Months Ended
	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020	Dec. 31, 2019
Equity Transactions
Noncash gain on extinguishment of debt	$ 1,148,554						$ 1,148,554
Net income (loss)	(261,285)	$ 75,544	$ 1,743,060	$ (559,294)	$ 1,461,516	$ (1,830,965)	1,557,319	$ (928,743)
Noncash gain on forgiveness of debt	146,685						146,685
Accumulated deficit	(55,416,744)						(55,416,744)		$ (56,974,063)
Total stockholders' deficit	(7,260,817)	$ (7,199,532)	$ (10,713,667)	$ (10,597,737)	$ (10,038,443)	$ (11,499,959)	(7,260,817)	(10,597,737)	(12,456,727)	$ (9,668,994)
Derivative liabilties	2,241,678						2,241,678
Working capital deficit	(7,160,701)						(7,160,701)
Net cash used in operating activities							(726,251)	$ (392,301)
Cash and cash equivalents	$ 133,584						$ 133,584		$ 36,516

Significant Accounting Polici_4

Significant Accounting Policies (Details) - USD ($)	Sep. 30, 2021	Dec. 31, 2020
Derivative Liability	$ 1,728,274
Derivative Liability	0	$ 3,845,662
Level 1 [Member]
Derivative Liability	0
Level 2 [Member]
Derivative Liability	0
Level 3 [Member]
Derivative Liability	$ 0

Significant Accounting Polici_5

Significant Accounting Policies (Details 1) - USD ($)	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Significant Accounting Policies
Balance, beginning of year	$ 3,845,662	$ 2,349,471
Additions	124,290	368,312
Extinguished derivative liability	(1,728,274)	0
Change in fair value of derivative liabilities	(2,241,678)	(376,282)
Balance, ending of period	$ 0	$ 2,341,501

Significant Accounting Polici_6

Significant Accounting Policies (Details 2) - USD ($)	3 Months Ended		6 Months Ended	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Jun. 30, 2021	Sep. 30, 2021	Sep. 30, 2020
Significant Accounting Policies
Net income attributable to common shareholders				$ 1,557,319
Change in fair value of derivative liabilities				(2,241,678)	$ (376,282)
Gain on extinguishment of debt			$ (1,148,554)	(1,148,554)
Expense attributable to note derivatives
Interest expense				216,378
Diluted loss attributable to common shareholders				$ (1,616,535)
Basic shares outstanding				4,494,649
Derivative notes and interest shares				3,866,301
Diluted shares outstanding				8,360,950
Diluted loss per share	$ (0.03)	$ (2.01)		$ (0.19)	$ (3.34)

Significant Accounting Polici_7

Significant Accounting Policies (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Amortization expense	$ 4,795	$ 4,459	$ 14,045	$ 13,110
Future warranty expenses	$ 91,531		$ 91,531		$ 91,531
Common share excluded from diluted earnings per share	7,193,399	7,193,399	14,624,579	14,624,579
Inventory raw materials	$ 73,094		$ 73,094		48,734
Inventory in process	3,953		3,953		4,843
Inventory finished goods	15,870		15,870		$ 12,079
2021			18,200
2022			18,200
2023			18,200
2024			18,200
2025			18,200
Thereafter			18,200
Depreciation expense	367	$ 6,493	1,722	$ 20,191
Proceeds for research and development expenses	28,651	34,716	89,617	92,050
Research and development expenses	58,465	45,289	159,277	176,849
Royalty revenues			0	0
License fees revenue	$ 12,500	$ 12,500	$ 37,500	$ 37,500
Estimated useful lives of patents			17 years
Leasehold Improvements [Member]
Property plant and equipment, estimated useful lives			the shorter of their estimated useful lives of 5 years or the related lease term
Minimum [Member]
Property and equipment estimated useful life			3 years
Maximum [Member]
Property and equipment estimated useful life			7 years
Account receivables [Member]
Concentration of risk, percentage			100.00%		100.00%
Revenue [Member]
Concentration of risk, percentage			75.00%	71.00%

Accrued Expenses Other (Details

Accrued Expenses Other (Details) - USD ($)	Sep. 30, 2021	Dec. 31, 2020
Accrued Expenses Other
Accrued expenses, other	$ 189,278	$ 185,656
Accrued common stock to be issued for financing cost	120,990	0
Accrued interest	898,067	1,238,553
Accrued warranty costs	91,531	91,531
Total accrued Expenses	$ 1,299,866	$ 1,515,740

Related Party Transactions (Det

Related Party Transactions (Details Narrative) - USD ($)	Oct. 12, 2019	Jun. 24, 2016	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Accrued interest					$ 1,200
Rent expense			$ 12,198	$ 12,198	$ 36,594	$ 36,594
Lease term description					The lease term will terminate upon 30 days’ written notice from landlord or 90 days written termination from us. The lease is considered to be short term or month to month
Building [Member]
Monthly rent expense					$ 4,066
Chief Executive Officer [Member]
Debt instrument maturity date	Oct. 12, 2021
Interest expense			150	$ 150	450	$ 450
Interest bearing per year	10.00%
Accrued compensation			$ 2,053,878		$ 2,053,878		$ 1,983,639
Promissory note	$ 10,000
Loan And Security Agreement [Member] | Patricia Tangredi [Member]
Principal amount and interest totaled		$ 3,040,838
Interest rate		12.00%
Senior secured debt, minimum interest payment		$ 2,000
Principal loan amount		$ 150,000

Equity Transactions (Details Na

Equity Transactions (Details Narrative)	3 Months Ended	6 Months Ended	9 Months Ended
	Jun. 30, 2021USD ($)shares	Jun. 30, 2021USD ($)shares	Sep. 30, 2021USD ($)integer$ / sharesshares	Dec. 31, 2020integer$ / sharesshares
Common stock par value | $ / shares			$ 0.01	$ 0.01
Common stock shares issued, shares			9,415,425	278,757
Common stock purchase warrants	2,826,733	2,826,733
Common stock shares issued, amount | $	$ 1,829,534	$ 1,829,534
Common stock purchase warrants, amount | $	$ 857,600	$ 857,600
Common stock shares issued, shares	2,100,000	2,100,000
Common stock shares issued, amount | $	$ 567,000	$ 567,000
Common stock shares authorized			1,100,000,000	1,100,000,000
Shares and warrants issued for settlement of debt	7,036,668	7,036,668
Volatility rate			315.00%
Expected life			17 years
Dividend yield			0.00%
Debt [Member]
Fair value of warrants | $			$ 857,600
Risk free interest rate			0.05%
Volatility rate			367.00%
Expected life			11 years 6 months
Dividend yield			0.00%
Warrant expiry date			June 30, 2022
Warrants issued			2,826,733
Warrants, per price | $ / shares			$ 0.30
Note [Member]
Fair value of warrants | $			$ 110,000
Risk free interest rate			0.84%
Volatility rate			389.00%
Expected life			5 years
Dividend yield			0.00%
Warrant expiry date			September 21, 2026
Warrants issued			1,466,666
Warrants, per price | $ / shares			$ 0.15
Note amount | $			$ 220,000
Warrants [Member]
Exercise price | $ / shares			$ 0.05
Common stock shares issued for service	700,000
Fair value of warrants | $			$ 184,457
Risk free interest rate	0.06%
Volatility rate	376.00%
Expected life	1 year
Dividend yield	0.00%
Warrant expiry date	May 18, 2022
Board of Directors [Member]
Preferred stock shares authorized			10,000,000	10,000,000
Preferred stock, par value | $ / shares			$ 0.01	$ 0.01
Preferred Stock, Series B [Member]
Preferred stock, shares par value | $ / shares			$ 0.01	$ 0.01
Preferred stock shares authorized			10,000	10,000
Voting right description			equal to 51% of the votes to approve certain corporate actions, including, without limitation, changing the name of the Company and increasing the number of authorized shares
Preferred Stock Undesignated [Member]
Class A preferred stock shares			2,000,000	2,000,000
Preferred stock, shares par value | $ / shares			$ 0.01	$ 0.01
Preferred stock shares authorized			7,990,000	7,990,000
Preferred Stock, Series A [Member]
Preferred stock shares authorized			2,000,000	2,000,000
Conversion price description			The Conversion Price shall be equal to the 75% of the average closing price for the 30 trading days prior to the election to convert
Per share | $ / shares			$ 1.50	$ 1.50
Voting power			49.00%
Preferred stock, number of votes | integer			150	150

Notes Payable (Details Narrativ

Notes Payable (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Amortization of debt discount			$ 32,557	$ 101,899
Forgiveness of debt income	$ 146,685	$ 0	146,685	0
Fair value of the warrants			$ 110,000	$ 0
Risk free interest rate			0.01%
Dividend yield			0.00%
Volatility rate			315.00%
Expected life			3 years
GS Capital Partners, LLC [Member]
Maturity date			Sep. 20, 2022
Original issue discount			$ 20,000
Debt issuance related cost			3,000
Proceeds rom issuance of debt			$ 197,000
Warrants issued to purchase common shares			1,466,666
Warrant exercise price			$ 0.15
Fair value of the warrants			$ 110,000
Risk free interest rate			0.84%
Dividend yield			0.00%
Volatility rate			389.00%
Expected life			5 years
Fixed conversion price			$ 0.10
Beneficial conversion feature			$ 90,000
Debt discount			220,000
Deferred debt costs			3,000
Amortized interest expense			$ 6,721
Interest rate			8.00%
August 30, 2021 [Member] | GEX Management, Inc. [Member]
Maturity date			Feb. 28, 2022
Common stocl shares issuable			1,000,000
Common stocl shares issuable, value			$ 120,990
Amortization of debt discount	$ 25,836		$ 25,836
Interest rate			10.00%
January 25, 2021 [Member] | Senior Promissory Notes [Member]
Interest rate			1.00%
Loan agreement amount			$ 122,340
Debt instrument, payment terms			If not forgiven, the terms on the note provide for interest at 1% per year and the note mature in 24 months, with 18 monthly payments of $8,146 beginning after the initial 6 month deferral period for payments
June 12, 2020 [Member] | Small Business Administration Loan [Member]
Interest rate			3.75%
Loan agreement amount			$ 150,000
Debt instrument, payment terms			Installment payments, including principal and interest, of $731 monthly, will begin 12 months from the date of the note. The balance of principal and interest will mature 30 years from the date of the note
April 29, 2020 [Member] | Paycheck Protection Program [Member]
Interest rate			1.00%
Loan agreement amount			$ 144,750
Debt instrument, payment terms			If not forgiven, the terms on the note provide for interest at 1% per year and the note mature in 24 months, with 18 monthly payments of $8,146 beginning after the initial 6 month deferral period for payments
Forgiveness of debt income			$ 146,685
Accrued interest forgiven			$ 1,935
April 2021 [Member] | JMS Investments of Staten Island [Member]
Interest rate			8.50%
Initial investment			$ 376,000

Convertible Notes Payable and_3

Convertible Notes Payable and Exchange Program (Details) - USD ($)	Sep. 30, 2021	Dec. 31, 2020
Convertible Notes Payable and Exchange Program
Convertible notes payable, bearing interest at 8- 10%	$ 0	$ 1,453,960
Current portion	$ 0	$ 1,453,960

Convertible Notes Payable and_4

Convertible Notes Payable and Exchange Program (Details Narrative) - USD ($)	6 Months Ended	9 Months Ended
	Jun. 30, 2021	Sep. 30, 2021	Sep. 30, 2020	May 31, 2021	Dec. 31, 2020
Amortization of deferred debt issue costs			$ 5,848
Amortization of debt discount			101,899
Accrued interest expenses	$ 653,454		0
Settlement of debt	$ 1,453,960
Warrants issued	2,826,733
Common stock valued		$ 94,154			$ 2,788
Derivative liability		1,728,274
Accrued interest expenses		388,764	$ 412,291
Gain on extingushment	$ 1,148,554	$ 1,148,554
Warrants valued	$ 857,600
2017 June Notes [Member]
Convertible notes payable				$ 2,107,414	$ 2,008,812
Strike price		$ 0.030
Common shares issued	7,036,668
Warrants issued		2,826,733
Common stock valued	$ 1,829,534
2018 Notes [Member]
Convertible notes payable		$ 1,453,960
Common shares issued		7,036,668
Warrants issued	3,576,733
Derivative liability	$ 1,728,274
Accrued interest expenses		$ 653,454
Gain on extingushment	1,148,554
Warrants valued	$ 857,600

Derivative Liabilities (Details

Derivative Liabilities (Details Narrative) - USD ($)	3 Months Ended			6 Months Ended	9 Months Ended
	Sep. 30, 2021	Jun. 30, 2021	Sep. 30, 2020	Jun. 30, 2021	Sep. 30, 2021	Sep. 30, 2020
Derivative Liabilities
Gain on extingushment				$ 1,148,554	$ 1,148,554
Shares and warrants issued for settlement of debt, value				$ 1,829,534
Warrants issued				2,826,733
Settlement of debt				$ 1,453,960
Warrants valued				857,600
Accrued interest		$ 653,454		$ 653,454
Shares and warrants issued for settlement of debt		7,036,668		7,036,668
Change in fair value of derivative liabilities	$ 0		$ (208,916)		2,241,678	$ 376,282
Non-cash interest expenses	0		$ 106,366		124,290	368,312
Derivative liability extinguished				$ 1,728,274	1,728,274	$ 0
Derivative liability	$ 1,728,274				$ 1,728,274
Risk free interest rate					0.01%
Volatility rate					315.00%
Expected life					3 years
Dividend yield					0.00%

Commitments and Contingencies_2

Commitments and Contingencies (Details)	9 Months Ended
	Sep. 30, 2021USD ($)
Sum Owned	$ 124,459
Old Dominion Freight Line [Member]
Sum Owned	$ 13,576
Payment Plan	No
Legal Action	Yes
SoftinWay[Member]
Sum Owned	$ 15,350
Payment Plan	Yes
Legal Action	Yes
The O-Ring Store [Member]
Sum Owned	$ 10,334
Payment Plan	No
Legal Action	Yes
Power Plant Services [Member]
Sum Owned	$ 85,199
Payment Plan	No
Legal Action	Yes

Commitments and Contingencies_3

Commitments and Contingencies (Details Narrative) - Soex [Member] - October 8, 2021 [Member]	9 Months Ended
	Sep. 30, 2021USD ($)
Attorneys fees	$ 300,568
Cost related to defendant	82,096
Total award to defendant	$ 382,664

Subsequent Event (Details)

Subsequent Event (Details) - JMS Investments, LLC [Member]	Sep. 30, 2021USD ($)
November 3, 2021 [Member]
Sum Received	$ 100,000
November 4, 2021 [Member]
Sum Received	30,000
November 2, 2021 [Member]
Sum Received	$ 30,000

Subsequent Event (Details Narra

Subsequent Event (Details Narrative) - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
April 2021 and November 2021 [Member]
Total investment	$ 536,000
Interest rate	8.50%
Chief Executive Officer [Member]
Accrued compensation	$ 2,053,878	$ 1,983,639
Warrant issued description	A Five-year cashless warrant for 5,134,690 shares with a strike price of $.08 will be issued to Employee to reduce the Company’s indebtedness by 75% leaving a balance of $536,000